Accelerating drug discovery process

"We believe that the IPO will help us gain improved global competitiveness. With the raised R&D fund, LegoChem will be able to go further in clinical study and drug development to generate more profits, and it will raise the possibility of deals at a global scale," said Prof Yong-Zu Kim.

The company's vision is to become a leading pharmaceutical company by holding more than five global clinical pipelines.